Literature DB >> 14613666

Sexually transmitted disease screening in teens.

Jill S Huppert1, Paula J Adams Hillard.   

Abstract

Sexually transmitted diseases (STDs) impose a tremendous health burden on women, and adolescent females are the group at the highest risk. Universal annual screening of all women younger than 25 years of age has been a best practice recommendation since 1997. When implemented, such screening leads to a decrease in disease prevalence and of serious sequelae, such as pelvic inflammatory disease (PID). However, STD screening rates in actual clinical practice fail to approach recommendations. In this review, we summarize findings from recent surveys of providers and adolescents, discuss barriers to STD screening, and offer strategies for individual clinicians to improve STD screening rates in practice.

Entities:  

Mesh:

Year:  2003        PMID: 14613666

Source DB:  PubMed          Journal:  Curr Womens Health Rep        ISSN: 1534-5874


  4 in total

Review 1.  Management of pelvic inflammatory disease in adolescents.

Authors:  Dilip R Patel
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

2.  Can a Multilevel STI/HIV Prevention Strategy for High Risk African American Adolescents Improve Life Satisfaction?

Authors:  Keith J Zullig; Robert F Valois; Gerald R Hobbs; Jelani C Kerr; Daniel Romer; Michael P Carey; Larry K Brown; Ralph J DiClemente; Peter A Vanable
Journal:  J Happiness Stud       Date:  2019-02-19

3.  Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record users.

Authors:  Elissa R Weitzman; Skyler Kelemen; Liljana Kaci; Kenneth D Mandl
Journal:  BMC Med Inform Decis Mak       Date:  2012-05-22       Impact factor: 2.796

4.  The appropriateness of gatekeeping in the provision of reproductive health care for adolescents in Lithuania:the general practice perspective.

Authors:  Lina Jaruseviciene; Gwenola Levasseur
Journal:  BMC Fam Pract       Date:  2006-03-14       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.